GB0409775D0 - Assay - Google Patents

Assay

Info

Publication number
GB0409775D0
GB0409775D0 GBGB0409775.4A GB0409775A GB0409775D0 GB 0409775 D0 GB0409775 D0 GB 0409775D0 GB 0409775 A GB0409775 A GB 0409775A GB 0409775 D0 GB0409775 D0 GB 0409775D0
Authority
GB
United Kingdom
Prior art keywords
analyte
antibody
cells
sample
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0409775.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mabtech AB
Original Assignee
Mabtech AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mabtech AB filed Critical Mabtech AB
Priority to GBGB0409775.4A priority Critical patent/GB0409775D0/en
Publication of GB0409775D0 publication Critical patent/GB0409775D0/en
Priority to EP05736132A priority patent/EP1740949B1/en
Priority to AU2005238635A priority patent/AU2005238635B2/en
Priority to CA2564826A priority patent/CA2564826C/en
Priority to US11/587,545 priority patent/US8790872B2/en
Priority to PCT/EP2005/004620 priority patent/WO2005106479A1/en
Priority to AT05736132T priority patent/ATE533053T1/de
Priority to JP2007509977A priority patent/JP4990129B2/ja
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
GBGB0409775.4A 2004-04-30 2004-04-30 Assay Ceased GB0409775D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0409775.4A GB0409775D0 (en) 2004-04-30 2004-04-30 Assay
EP05736132A EP1740949B1 (en) 2004-04-30 2005-04-29 Non-elispot assay
AU2005238635A AU2005238635B2 (en) 2004-04-30 2005-04-29 Non-elispot assay
CA2564826A CA2564826C (en) 2004-04-30 2005-04-29 Non-elispot assay
US11/587,545 US8790872B2 (en) 2004-04-30 2005-04-29 Non-elispot assay
PCT/EP2005/004620 WO2005106479A1 (en) 2004-04-30 2005-04-29 Non-elispot assay
AT05736132T ATE533053T1 (de) 2004-04-30 2005-04-29 Nicht-elispot-test
JP2007509977A JP4990129B2 (ja) 2004-04-30 2005-04-29 非ＥＬＩＳｐｏｔアッセイ法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0409775.4A GB0409775D0 (en) 2004-04-30 2004-04-30 Assay

Publications (1)

Publication Number Publication Date
GB0409775D0 true GB0409775D0 (en) 2004-06-09

Family

ID=32482521

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0409775.4A Ceased GB0409775D0 (en) 2004-04-30 2004-04-30 Assay

Country Status (8)

Country Link
US (1) US8790872B2 (enExample)
EP (1) EP1740949B1 (enExample)
JP (1) JP4990129B2 (enExample)
AT (1) ATE533053T1 (enExample)
AU (1) AU2005238635B2 (enExample)
CA (1) CA2564826C (enExample)
GB (1) GB0409775D0 (enExample)
WO (1) WO2005106479A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0409771D0 (en) * 2004-04-30 2004-06-09 Mabtech Ab Assay
EP1867988A1 (en) * 2006-06-12 2007-12-19 Centro Biotecnologie Avanzate Cytokine capture assay in high throughput format for determining antigen-specific T-cell responses
PT2367561E (pt) 2008-11-30 2015-10-23 Immusant Inc Composições e métodos para o tratamento da doença celíaca
WO2014115102A1 (en) * 2013-01-23 2014-07-31 Institut National De La Sante Et De La Recherche Medicale Number of il4 and/or il3 secreting t-cells as a biomarker for allergic diseases
WO2015038624A1 (en) 2013-09-10 2015-03-19 Immusant, Inc. Dosage of a gluten peptide composition
CA2962933A1 (en) 2014-09-29 2016-04-07 Immusant, Inc. Use of hla genetic status to assess or select treatment of celiac disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063810B1 (en) 1981-04-29 1986-03-05 Ciba-Geigy Ag New devices and kits for immunological analysis
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
GB8803000D0 (en) * 1988-02-10 1988-03-09 Ekins Roger Philip Determination of ambient concentrations of several analytes
WO1990004182A1 (en) 1988-10-14 1990-04-19 Virovahl S.A. A method for simultaneous detection of different types of antibodies and/or antigens produced by individual cells
SE465943B (sv) * 1988-10-14 1991-11-18 Virovahl Sa Metod foer samtidig detektering av olika analyter, spec antikroppar med "elispot" tekniken
FR2679659B1 (fr) 1991-07-23 1993-11-19 Medgenix Diagnostic Sa Procede de dosage in vitro de molecules au niveau de leur site de production par des cellules en culture et format technologique adapte.
US6410252B1 (en) * 1995-12-22 2002-06-25 Case Western Reserve University Methods for measuring T cell cytokines
DE19821289A1 (de) 1998-05-13 1999-11-18 Volkmar Schoellhorn Verfahren zur Bestimmung der Aktivität von menschlichen und tierischen Zellen, insbesondere Blutzellen, und Mikrotiterplatten
DE60009533T2 (de) 1999-10-13 2005-01-27 Incyte Corp., Palo Alto Multiple analyse von zytokinen
WO2002080982A2 (en) * 2001-01-12 2002-10-17 Chiron Corporation Nucleic acid mucosal immunization
EP1241476A1 (en) 2001-03-12 2002-09-18 Mabtech AB Diagnosis of metal allergy through cytokine release by T-cells in vitro
CA2459893C (en) 2001-09-10 2014-01-21 Meso Scale Technologies, Llc Methods and apparatus for conducting multiple measurements on a sample
AU2002342299A1 (en) 2001-10-31 2003-05-12 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Generation of use of tc1 and tc2 cells
KR100786054B1 (ko) * 2002-03-25 2007-12-17 다카라 바이오 가부시키가이샤 세포상해성 림프구의 제조방법
US20040049351A1 (en) * 2002-08-28 2004-03-11 Matson Robert S. Immunosorbent assay in microarray format
US20060079461A1 (en) * 2003-12-24 2006-04-13 Scios, Inc. Treatment of multiple myeloma by inhibition of p38 MAP kinase
GB0409771D0 (en) * 2004-04-30 2004-06-09 Mabtech Ab Assay

Also Published As

Publication number Publication date
EP1740949B1 (en) 2011-11-09
JP2007535668A (ja) 2007-12-06
CA2564826A1 (en) 2005-11-10
AU2005238635B2 (en) 2011-11-03
EP1740949A1 (en) 2007-01-10
AU2005238635A1 (en) 2005-11-10
CA2564826C (en) 2013-10-15
ATE533053T1 (de) 2011-11-15
WO2005106479A1 (en) 2005-11-10
US20080145837A1 (en) 2008-06-19
JP4990129B2 (ja) 2012-08-01
US8790872B2 (en) 2014-07-29

Similar Documents

Publication Publication Date Title
WO2007103859A3 (en) Methods, products, and kits for identifying an analyte in a sample
ATE528648T1 (de) Verfahren zum nachweis antikörper-herstellender zellen
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
WO2005106036A3 (en) Methods and compositions for assaying analytes
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
WO2010096674A3 (en) A+ biomarker assays
MX346499B (es) Dispositivos, metodos y kits de inmunocromatografia.
WO2006117161A3 (en) New labelling strategies for the sensitive detection of analytes
WO2011147563A8 (de) Verfahren zur elektrochemischen detektion von bindungsreaktionen
WO2006069023A3 (en) Assay method and apparatus with reduced sample matrix effects
WO2011142781A3 (en) Pore-limit electrophoresis (ple) microchannel assays
ATE447712T1 (de) Immunoassay mit doppelter standardkurve
WO2009111572A3 (en) Cell, method and kit for conducting an assay for neutralizing antibodies
WO2009055387A8 (en) Polymerized conjugates for biological applications
GB0409775D0 (en) Assay
DE602006005896D1 (de) Immunochromatografische Testvorrichtung
ATE405837T1 (de) Festphase immunochromatographische testverfahren
SG164389A1 (en) Detection of a therapeutic antibody in an experimental animal
WO2009126889A8 (en) Assays for detecting pregnancy-associated glycoproteins
WO2005094441A3 (en) Split enzyme linked immunosorbent and nucleic acid assays
WO2006029302A3 (en) Dioxetane-nanoparticle assemblies for energy transfer detection systems, methods of making the assemblies, and methods of using the assemblies in bioassays
WO2006020766A3 (en) Point source diffusion cell activity assay apparatuses and methods
WO2007037910A3 (en) Specific removal of activated immune cells
WO2006071970A3 (en) Methods for the detection of analytes in a sample

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)